Comparing the Effects of Psilocin and Psilocybin in Healthy Adults

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 26, 2022

Primary Completion Date

January 16, 2025

Study Completion Date

July 31, 2025

Conditions
Healthy
Interventions
DRUG

Psilocin

17.5mg oral psilocin with psychological support and physiological monitoring

DRUG

Psilocybin

25mg oral psilocybin with psychological support and physiological monitoring

DRUG

Sublingual Psilocin

2.18mg - 4.36mg sublingual psilocin with psychological support and physiological monitoring

Trial Locations (1)

94143

University of California, San Francisco, San Francisco

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Filament Health Corp.

INDUSTRY

lead

University of California, San Francisco

OTHER